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Vasa praevia is one of the causes of perinatal mortality and morbidity. In 2012, the Royal 
Australian and New Zealand College of Obstetricians and Gynaecologists issued the first 
national guidance on vasa praevia. This statement recommended screening women who 
have risk factors for vasa praevia, and early caesarean section for women with an 
antenatal diagnosis of vasa praevia. These interventions are to improve perinatal 
outcomes.  
The rarity of this condition has been a significant obstacle for health researchers to 
conduct high-impact quality studies to enable the development of a national clinical 
guideline. Hence, women with this condition often seem to receive different approaches 
from care providers, which has been shown to cause stress and worry in some women.  
Methods 
Utilising a mixed methods design, this thesis aimed to investigate the views of midwives 
and obstetricians regarding antenatal diagnosis of vasa praevia, describe the impact of 
perinatal deaths due to vasa praevia on these clinicians, and identify the actions 
required to improve the capabilities of these professional groups to care for the affected 
women. Phase one investigated the views and current practice of 453 obstetricians in 
Australia and New Zealand through a bi-national survey. In Phase two, a descriptive 
qualitative research, 22 obstetricians and 20 midwives practising across Australia were 
interviewed to explore the experience of caring for women with vasa praevia.  
Results 
There was a lack of consensus from obstetricians on the definition of vasa praevia. 
Despite high acceptability of screening women with risk factors for vasa praevia (70%), 
there was a low awareness (17%) about the risk factors. The qualitative study identified 
the devastating impact of adverse perinatal outcomes due to undiagnosed vasa praevia 
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on the midwives and obstetricians. This was a driving force for antenatal screening and 
diagnosis. However, lack of knowledge at the clinician level and lack of local policy, 
information for women and research about vasa praevia at the health system level were 
the reported barriers to the provision of safe, high-quality care.  
Conclusion 
The findings establish the need for standardising the process of screening, diagnosis and 
care of women with vasa praevia. This can be achieved by developing local policies at 
each ultrasound facility and maternity hospital, educating clinicians, and developing lay 
information for women affected by this condition. Furthermore, clinicians should be 
prepared and supported to deal with adverse patient outcomes, and work with families 
to improve experiences and outcomes.   
 
